Table 1.
Variable | N | M | SD | Min | Max |
Age (at consent) | 46 | 27.30 | 8.17 | 18 | 50 |
Gender (male) | 33 (71.74%) | – | – | – | – |
Gender (female) | 13 (28.26%) | – | – | – | – |
Age of illness onset (years) | 46 | 26.53 | 8.45 | 18 | 49 |
Duration from 1st psychotic symptom (days) to baseline antipsychotic (DUP) | 46 | 248.30 | 245.06 | 0 | 726 |
Duration from 1st contact with mental health services (days) to baseline antipsychotic | 46 | 346.57 | 600.37 | 6 | 2358 |
Chlorpromazine equivalents (mg/day) | 46 | 176.89 | 121.29 | 10 | 800 |
Number of hospital admissions | 46 | 0.89 | 0.64 | 0 | 3 |
Years of education | 42 | 13.62 | 2.82 | 5 | 20 |
CGI-SCH baseline score | 56 | Minimally ill=1 Mildly ill=4 Moderately ill=12 Markedly ill=15 Severely ill=12 Among the most severely ill=1 |
– | – | – |
Antipsychotic medication | 51 | Amisulpride=1 Aripiprazole=19 Olanzapine=16 Paliperidone=1 Quetiapine=4 Risperidone=5 |
– | – | – |
CGI-SCH, Clinician Rating Scale for Schizophrenia; DUP, duration of untreated psychosis.